Medtronic Payment of Deferred Purchase Consideration increased by 125.0% to $70.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 566.7%, from -$15.00M to $70.00M. Over 3 years (FY 2021 to FY 2025), Payment of Deferred Purchase Consideration shows an upward trend with a -12.3% CAGR.
isrg_payment_of_deferred_purchase_consideration| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$164.00M | -$4.00M | $447.00M | -$495.00M | $215.00M | $273.00M | -$120.00M | -$429.00M | -$133.00M | -$8.00M | -$56.00M | -$15.00M | $80.00M | $31.00M | -$280.00M | $70.00M |
| QoQ Change | — | +97.6% | >999% | -210.7% | +143.4% | +27.0% | -144.0% | -257.5% | +69.0% | +94.0% | -600.0% | +73.2% | +633.3% | -61.3% | <-999% | +125.0% |
| YoY Change | — | — | — | — | +231.1% | >999% | -126.8% | +13.3% | -161.9% | -102.9% | +53.3% | -87.5% | +242.9% | — | — | +566.7% |